Gain Insight and Control Through Your Cell Collection Data

The best possible starting material is critical to providing the best outcome.

Optimize Your Starting Material

Use Data to Drive Improvement of Your Cell Collections

Your manufacturing process is highly dependent on the quality of your starting material. Whether you are just starting your CAR T-cell therapy clinical trial or scaling up from phase 1 to phase 2, the starting material collected from the patient matters. No two patients are the same and collections can vary. Controlling what you can becomes all the more important.

Let our expertise paired with your procedural data provide a roadmap for achieving your goals.

Enhanced strategy

Data-driven decisions

Visibility into the process

Optimized starting product

Achievement of therapy objectives

Variability in CAR T-cell expansion may cause the contamination of the starting peripheral blood mononuclear cell (PBMC) concentrates with monocytes (non-target cells).¹

Our Services

Spectra Optia Cell Collection Data Analytics

Single or multiple procedure data analysis
Comprehensive analysis from pre-procedure data through final therapy results
Optimization recommendations
Collection site comparison and benchmarking
On-site and off-site systems support

Spectra Optia Prediction Algorithm

Collection data review
Customized whole blood process calculation
Statistical summary analysis

¹Stroncek DF, Ren J, Lee DW, et al. Myeloid cells in peripheral blood mononuclear cell concentrates inhibit the expansion of chimeric antigen receptor T Cells. Cytotherapy. 2016;18(7):898-901.

Materials

Cellular Acquisitions: Challenges, Methods, and Solutions for Obtaining Optimal Starting Material
Download

White Paper: Cell Collection Basics – Introduction and Fundamentals for HSCT and C&GT Industries
Download

Case Study: Data Analysis of HSC Collections Helps Improve Performance and Reduce Collection Days
Download

Customer Success Story: Hospital Increases the Mean Hematopoietic Stem Cell Yield Yield and CD34+ Collection Efficiency By 32%
Download

Customer Success Story: Improved cell collections of target yields from 47% to 92%
Download

Veda Solutions: Spectra Optia Cell Collection Analytics Brochure
Download

On-Demand Webinar: Challenges of Cell Collections for Cell Therapy Manufacturing: What Do We Want in the Bag?
Panel includes Krishnendu Roy, PhD; Sandeep Soni, MD; and Melinda Caltabano
Register Now

{{$index+1}}. {{s.label}}